Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats

European Journal of Pharmacology

Volumn 361, Issue 1, 1998, Pages 17-26

  Engelmann, Mario ^a   Landgraf, Rainer ^a   Lörscher, Patrick ^a   Conzelmann, Charlotte ^a   Probst, Joseph C ^a   Holsboer, Florian ^a   Reul, Johannes M H M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antisense targeting; Hippocampus; Morris water maze; Spatial navigation

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PHOSPHOROTHIOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SPATIAL DISCRIMINATION;

ANIMALS; BRAIN; DOWN-REGULATION; HIPPOCAMPUS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, INBRED BN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SPATIAL BEHAVIOR; SWIMMING;

EID: 0031721972     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00702-X     Document Type: Article

References (39)

1. Bodnoff S.R., Humphreys A.G., Lehman J.C., Diamond D.M., Rose G.M., Meaney M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15:1995;61-69.
2. Brandeis R., Brandys Y., Yehuda S. The use of the Morris water maze in the study of memory and learning. Intern. J. Neurosci. 48:1989;29-69.
3. Buresova O., Bures J. The significance of crossed and uncrossed projections for the acquisition and retrieval of visual engrams in hooded and albino rats. Psychol. Forsch. 35:1971;46-56.
4. Dallman M.F., Akana S.F., Jacobson L., Levin N., Cascio C.S., Shinsako J. Characterization of corticosterone feedback regulation of ACTH secretion. Ann. NY Acad. Sci. 512:1987;402-414.
5. Dallman M.F., Akana S.F., Strack A.M., Hanson E.S., Sebastian R.J. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann. NY Acad. Sci. 771:1995;730-742.
6. de Kloet E.R., Reul J.M.H.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology. 12:1987;83-105.
7. Fuxe K., Wikstrom A.C., Okret S., Agnati L.F., Harfstrand A., Yu Z.Y., Granholm L., Zoli M., Vale W., Gustafsson J.A. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 117:1985;1803-1812.
8. Kaminsky Y., Bureš J., Nerad L., Krekule I. A new IBM PC based system for automation of the Morris water tank experiments. Physiol. Res. 41:1992;26P.
9. Korte S.M., De Kloet E.R., Buwalda B., Bouman S.D., Bohus B. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Eur. J. Pharmacol. 301:1996;19-25.
10. Landgraf R., Gerstberger R., Montkowski A., Probst J.C., Wotjak C.T., Holsboer F., Engelmann M. V1 vasopressin receptor antisense oligodeoxynucleotide administration into septum reduces vasopressin binding, social discrimination abilities and anxiety-related behavior in rats. J. Neurosci. 15:1995;4250-4258.
11. Liebsch G., Landgraf R., Gerstberger R., Probst J.C., Wotjak C.T., Engelmann M., Holsboer F., Montkowski A. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Pept. 59:1995;229-239.
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall N.J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
13. Luttge W.G., Davda M.M., Rupp M.E., Kang C.G. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in mouse brain. Endocrinology. 125:1989;1194-1203.
14. Mani S.K., Blaustein J.D., Allen J.M., Law S.W., O'Malley B.W., Clark J.H. Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology. 135:1994;1409-1414.
15. McCarthy M.M., Kleopoulos S.P., Mobbs C.V., Pfaff D.W. Infusion of antisense oligonucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat. Neuroendocrinology. 59:1994;432-440.
16. Miesfeld R., Rusconi S., Godowski P.J., Maler B.A., Okret S., Wilkstroem A.-C., Gustafsson J.-A., Yamamoto K.R. Genetic complementation to a glucocorticoid receptor deficiency by expression of a cloned receptor cDNA. Cell. 46:1986;389-399.
17. Morris R.G.M. Spatial localization does not require the presence of local cues. Learning Motiv. 12:1981;239-260.
18. Oitzl M.S., de Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106:1992;62-71.
19. Oitzl M.S., Fluttert M., de Kloet E.R. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur. J. Neurosci. 6:1994;1072-1979.
20. Oitzl M.S., van Haarst A.D., Sutanto W., de Kloet E.R. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology. 20:1995;655-675.
21. Patacchioli F.R., Puglisi-Allegra S., Maccari S., Casolini P., Angelucci L., Cabib S., Oliverio A. Strain-dependent differences in hippocampal glucocorticoid binding capacity and active avoidance in the mouse. Behav. Brain Res. 37:1990;185-188.
22. Patel P.D., Sherman T.G., Goldman D.J., Watson S.J. Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus. Mol. Endocrinol. 3:1989;1877-1885.
23. Pezeshki G., Schöbitz B., Pohl T., Reul J.M.H.M. Intracerebroventricular administration of missense oligodeoxynucleotide induces interleukin-6 mRNA expression in brain and spleen of rats. Neurosci. Lett. 217:1996;97-100.
24. Pilowsky P.M., Suzuki S., Minson J.B. Antisense oligonucleotides: a new tool in neuroscience. Clin. Exp. Pharmacol. Physiol. 21:1994;935-944.
25. Reul J.M.H.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 117:1985;2505-2515.
26. Reul J.M.H.M., de Kloet E.R. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vivo autoradiography and computerized image analysis. J. Steroid Biochem. 24:1986;269-272.
27. Reul J.M.H.M., De Kloet E.R., Van Sluijs F.J., Rijnberk A., Rothuizen J. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology. 127:1990;907-915.
28. Reul J.M.H.M., Probst C.J., Skutella T., Stec I.S.M., Montkowski A., Landgraf R., Holsboer F. Increased hypothalamic-pituitary-adrenal axis reactivity after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligonucleotides. Neuroendocrinology. 65:1997;189-199.
29. Reul J.M.H.M., Stec I., Wiegers G.J., Labeur M.S., Linthorst A.C.E., Arzt E., Holsboer F. Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. J. Clin. Invest. 93:1994;2600-2607.
30. Reul J.M.H.M., Stec I., Söder M., Holsboer F. Treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 133:1993;312-320.
31. Roozendaal B., Bohus B., McGaugh J.L. Dose-dependent supression of adrenocortical activity with metyrapone: Effects on emotion and memory. Psychoneuroendocrinology. 21:1996;681-693.
32. Rupprecht R., Reul J.M.H.M., van Steensel B., Spengler D., Söder M., Berning B., Holsboer F., Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 247:1993;145-154.
33. Sakai R.R., Ma L.Y., Zhang D.M., McEwen B., Fluharty S.J. Intracerebral administration of mineralocorticoid receptor antisense oligonucleotides attenuate adrenal steroid-induced salt appetite in rats. Neuroendocrinology. 64:1996;425-429.
34. Spencer R.L., Young E.A., Choo P.H., Mc Ewen B.S. Adrenal steroid type-I and type-II receptor binding - estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res. 514:1990;37-48.
35. Sutanto W., de Kloet E.R. ZK 91587: a novel synthetic anti mineralocorticoid displays high affinity for corticosterone (type I) receptors in rat hippocampus. Life Sci. 43:1988;1537-1543.
36. Tonkiss J., Shultz P., Galler J.R. Long-Evans and Sprague-Dawley rats differ in their spatial navigation performance during ontogeny and at maturity. Dev. Psychobiol. 25:1992;567-579.
37. Wahlestedt C., Merlo Pich E., Koob G.F., Yee F., Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides. Science. 259:1993;528-530.
38. Yau J.L., Morris R.G.M., Seckl J.R. Hippocampal corticosteroid receptor mRNA expression and spatial learning in the aged Wistar rat. Brain Res. 657:1994;59-64.
39. Yau J.L., Olsson T., Morris R.G.M., Meaney M.J., Seckl J.R. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience. 66:1995;571-581.